Thiamine-responsive megaloblastic anemia syndrome (TRMA) with cone-rod dystrophy
- PMID: 11135496
Thiamine-responsive megaloblastic anemia syndrome (TRMA) with cone-rod dystrophy
Abstract
Thiamine-responsive megaloblastic anemia (TRMA) is an autosomal recessive disease in which the active thiamine uptake into cells is disturbed. The molecular basis underlying the disorder has been related to mutations in the gene SLC19A2 on chromosome 1q23.3 that encodes a functional thiamine transporter. The protein is predicted to have 12 transmembrane domains. TRMA is characterized by sensorineural deafness, diabetes mellitus, megaloblastic anemia, and cardiomyopathy. Optic nerve atrophy and retinal dystrophy have been reported in a small number of patients. We report a 15-year-old girl with TRMA and cone-rod dystrophy and confirm that retinal dystrophy may form part of the syndrome. Differential diagnosis of syndromes with deafness, diabetes mellitus, and optic nerve atrophy or retinal dystrophy are discussed. The authors suggest that ERG be performed in all patients with TRMA.
Similar articles
-
Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome.Nat Genet. 1999 Jul;22(3):309-12. doi: 10.1038/10385. Nat Genet. 1999. PMID: 10391223
-
Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness.Nat Genet. 1999 Jul;22(3):300-4. doi: 10.1038/10372. Nat Genet. 1999. PMID: 10391221
-
Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness.Turk J Pediatr. 2009 May-Jun;51(3):301-4. Turk J Pediatr. 2009. PMID: 19817279
-
Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport.Blood Cells Mol Dis. 2001 Jan-Feb;27(1):135-8. doi: 10.1006/bcmd.2000.0356. Blood Cells Mol Dis. 2001. PMID: 11358373 Review.
-
Cardiac manifestations in thiamine-responsive megaloblastic anemia syndrome.Pediatr Cardiol. 2003 Sep-Oct;24(5):476-81. doi: 10.1007/s00246-002-0215-3. Pediatr Cardiol. 2003. PMID: 14627317 Review.
Cited by
-
Thiamine responsive megaloblastic anemia syndrome.Indian J Pediatr. 2009 Mar;76(3):313-4. doi: 10.1007/s12098-009-0058-5. Epub 2009 Apr 6. Indian J Pediatr. 2009. PMID: 19347672
-
Vitamin B1 (thiamine) uptake by human retinal pigment epithelial (ARPE-19) cells: mechanism and regulation.J Physiol. 2007 Jul 1;582(Pt 1):73-85. doi: 10.1113/jphysiol.2007.128843. Epub 2007 Apr 26. J Physiol. 2007. PMID: 17463047 Free PMC article.
-
Does early treatment prevent deafness in thiamine-responsive megaloblastic anaemia syndrome?J Clin Res Pediatr Endocrinol. 2011;3(1):36-9. doi: 10.4274/jcrpe.v3i1.08. Epub 2011 Feb 23. J Clin Res Pediatr Endocrinol. 2011. PMID: 21448333 Free PMC article.
-
Importance of Immediate Thiamine Therapy in Children with Suspected Thiamine-Responsive Megaloblastic Anemia-Report on Two Patients Carrying a Novel SLC19A2 Gene Mutation.J Pediatr Genet. 2020 Oct 8;11(3):236-239. doi: 10.1055/s-0040-1717136. eCollection 2022 Sep. J Pediatr Genet. 2020. PMID: 35990029 Free PMC article.
-
Loss-of-Function Mutation in Thiamine Transporter 1 in a Family With Autosomal Dominant Diabetes.Diabetes. 2019 May;68(5):1084-1093. doi: 10.2337/db17-0821. Epub 2019 Mar 4. Diabetes. 2019. PMID: 30833467 Free PMC article.